Novii_SAR_Considerations V1-0

FCC ID: YOM-6960-MON

RF Exposure Info

Download: PDF
FCCID_3677783

DOCUMENT REVISION PAGE 1-0 1/7 Product Novii System Document name Novii System Document type Technical This document specifies the technical details Novii System Abstract MONICA HEALTHCARE LTD PROPRIETARY INFORMATION Copyright © 2005 by MONICA HEALTCARE LTD. All rights reserved. This document and the information contained therein are MONICA HEALTCARE LTD’s exclusive property. Any copy and/or disclosure thereof in any form whatsoever are subject to MONICA HEALTCARE LTD’s prior written consent.

DOCUMENT REVISION PAGE 1-0 2/7 DOCUMENT HISTORY SURNAME First name Responsibility Date Signature Issued by Branson Simon Engineering 15 Nov. 2017 REVISION WRITTEN BY DATE DESCRIPTION/CHANGES INDEX 1-0 Simon Branson 30/11/17 First Issue MONICA HEALTHCARE LTD PROPRIETARY INFORMATION Copyright © 2005 by MONICA HEALTCARE LTD. All rights reserved. This document and the information contained therein are MONICA HEALTCARE LTD’s exclusive property. Any copy and/or disclosure thereof in any form whatsoever are subject to MONICA HEALTCARE LTD’s prior written consent.

DOCUMENT REVISION PAGE 1-0 3/7 CONTENTS SAR Considerations for Novii System POD Calculations Interface Unit Calculation Calculations Conclusions MONICA HEALTHCARE LTD PROPRIETARY INFORMATION Copyright © 2005 by MONICA HEALTCARE LTD. All rights reserved. This document and the information contained therein are MONICA HEALTCARE LTD’s exclusive property. Any copy and/or disclosure thereof in any form whatsoever are subject to MONICA HEALTCARE LTD’s prior written consent.

DOCUMENT REVISION PAGE 1-0 4/7 This document details the SAR considerations for the Novii System. For the FCC non ionising radiation limits are given; see extract from FCC publication section 4.3 a) Section 4.3 a) For 100 MHz to 6 GHz and test separation distances ≤ 50 mm, the 1-g and 10-g SAR test exclusion thresholds are determined by the following: [(max. power of channel, including tune-up tolerance, mW) / (min. test separation distance, mm)] · [√f(GHz)] ≤ 3.0 for 1-g SAR, and ≤ 7.5 for 10-g extremity SAR,30 where f(GHz) is the RF channel transmit frequency in GHz MONICA HEALTHCARE LTD PROPRIETARY INFORMATION Copyright © 2005 by MONICA HEALTCARE LTD. All rights reserved. This document and the information contained therein are MONICA HEALTCARE LTD’s exclusive property. Any copy and/or disclosure thereof in any form whatsoever are subject to MONICA HEALTCARE LTD’s prior written consent.

CQA Report No.: CQASZ170701391EW—02 1 SAR Evaluation 1.1 RF Exposure Compliance Requirement 1.1.1 Standard Requirement According to KDB447498D01 General RF Exposure Guidance vO6 4.3.1. Standalone SAR test exclusion considerations Unless specifically required by the published RF exposure KDB procedures, standalone 1—g head or body and 10—g extremity SAR evaluation for general population exposure conditions, by measurement or numerical simulation, is not required when the corresponding SAR Exclusion Threshold condition, listed below, is satisfied. 1.1.2 Limits The 1—g and 10—g SAR test exclusion thresholds for 100 MHz to 6 GHz at test separation distances < 50 mm are determined by: [(max power of channel, including tune—up tolerance, mW)/(min. test separation distance, mm}] > [vf(GHz)] < 3.0 for 1—g SAR and = 7.5 for 10—g extremity SAR, where f(GHz) is the RF channel transmit frequency in GHz Power and distance are rounded to the nearest mW and mm before calculation‘" The result is rounded to one decimal place for comparison The test exclusions are applicable only when the minimum test separation distance is < 50 mm and for transmission frequencies between 100 MHz and 6 GHz. When the minimum test separation distance is < 5 mm, a distance of 5 mm is applied to determine SAR test exclusion 1.1.3EUT RF Exposure For BLE: Measurement Data GESK mode Test channel Peak Output Power (dBm)} Lowest —0.55 Middle 0.59 Highest 0.88 The Max Conducted Peak Output Power is 0.88dBm in Highest channel(2.480GHz); The best case gain of the antenna is 1.0dBi. EIRP= 0.88dBm + 1.00Bi =1.88dBm 1.88dBm logarithmic terms convert to numeric result is nearly 1.54mW According to the formula. calculate the EIRP test result: [{max. power of channel, including tune—up tolerance, mW)/{min. test separation distance, mm})] N(GHz)] General RF Exposure = (1.54mW / 5 mm ) x v2.480GHz = 0.485 I) SAR requirement: S 3.0 @; ® <@. So the SAR report is not required. Remark: The Max Conducted Peak Output Power data refer to report CQASZ170701391EW—01. Page:1 of 1

DOCUMENT REVISION PAGE 1-0 6/7 POD For the POD, from the FCC extract the calculation is: Power/Separation * sqrt (frequency) < 3 (SAR requirement) 1-g The Panasonic module data sheet states a maximum power of 10.5 dBm (11.22 mW). Frequency is 2.441 GHz, sqrt (2.441GHz) = 1.56 Separation is 7mm (measured using Vernier gauge from the antenna on the PCB to the part in contact with the skin) Calculation is 11.22mW / 7mm * sqrt(2.48GHz) = 2.52. The POD is therefore SAR test excluded because it is less than 3.0. It would also meet SAR test exclusion at 6mm separation. MONICA HEALTHCARE LTD PROPRIETARY INFORMATION Copyright © 2005 by MONICA HEALTCARE LTD. All rights reserved. This document and the information contained therein are MONICA HEALTCARE LTD’s exclusive property. Any copy and/or disclosure thereof in any form whatsoever are subject to MONICA HEALTCARE LTD’s prior written consent.

DOCUMENT REVISION PAGE 1-0 7/7 Interface Unit For the Interface, from the FCC extract the calculation is: Power/Separation * sqrt (frequency) < 7.5 (SAR requirement) 10-g Assume the power is 2 x POD power = 22.5mW (excluding wireless charger) Frequency is 2.441 GHz, sqrt (2.441GHz) = 1.56 Separation is 5mm 22.5/5*1.56 = 7.02 therefore SAR exempt < 7.5 (SAR 10-g requirement) Also, for the Interface Unit, we state that the user is > 20cm away in the Instructions for Use and is therefore SAR exempt. End of Document MONICA HEALTHCARE LTD PROPRIETARY INFORMATION Copyright © 2005 by MONICA HEALTCARE LTD. All rights reserved. This document and the information contained therein are MONICA HEALTCARE LTD’s exclusive property. Any copy and/or disclosure thereof in any form whatsoever are subject to MONICA HEALTCARE LTD’s prior written consent.


Document Created: 2017-12-04 16:13:06
Document Modified: 2017-12-04 16:13:06
© 2024 FCC.report
This site is not affiliated with or endorsed by the FCC